The prospect of very-low-nicotine cigarettes becoming the next alternative product on the US market has come a significant step closer, with the US Food and Drug Administration (FDA) issuing modified risk orders for two products from 22nd Century Group.

The company’s VLN King and VLN Menthol King, which contain around 96% less nicotine than normal combustibles, are the first to be accepted by the agency as modified risk tobacco products (MRTP).


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us